Кариотип клеток костного мозга при рецидивах острого миелоидного лейкоза у детей
Е. В. Флейшман, Sokova Oi, А. В. Попа et al. · Клиническая онкогематология. Фундаментальные исследования и клиническая практика · 2009
Karyotype abnormalities in bone marrow cells at relapses of pediatric acute myeloid leukemia (AML) has been studied. A comparison of chromosome characteristics at diagnosis (290 children) and at relapse (39 patients) was performed. In the majority of the cases cell clones with various abnormalities have been found. Karyotype evolution was observed in more than half of cases (61.9 %%) studied at diagnosis as well as at relapse. Additional chromosome abnormalities detected at relapses were not typical for pretreatment AML. A complex karyotype was frequently appeared as a result of the evolution. At relapses a proportion of cases with one-two chromosome abnormalities decreased (38.5 %% instead of 62.7 °%) but proportion of cases with complex karyotype increased (42.1 %% instead 17.2 %%, p = 0.000). Complex karyotype is known as cytogenetic criterion of adverse prognosis. Possibly poor treatment outcome of relapsed patients is partly connected with complex karyotype. Dependence of complete remission (CR) rate from initial karyotype was studied in cohort of cases (46 relapsed patients) whose karyotype was analysed at diagnosis. Accordingly to MRC classification (1998) the cohort was divided into three groups: good-risk, intermediate-risk and poor-risk. Second CR was achieved in 15 out of 19 patients of the first group (78.9 %), in 12 out of 20 (60 %) of the second group and in 3 out of 7 (42.8 %) of the third group. The distinction between the first and the third group was statistically significant (p = 0.029). Thus we confirmed that the outcome of relapse treatment certainly depends on karyotype at diagnosis.
Cited by 0 works.